Protective effect of silver nano particles against ovarian polycystic induced by morphine in rat

Document Type: Original Research Article

Authors

1 Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran

2 Department of Pathology, School of Medicine, Shahed University, Tehran, Iran

3 Department of Physics, Faculty of Basic Sciences, Shahed University, Tehran, Iran

Abstract

Background and Objective: Morphine can cause harmful effects in the ovaries. The silver nanoparticles (Ag-NPs) used in health care because of antimicrobial properties, can diffuse into the brain blood barrier. This study investigated the protective effect of Ag-NPs on the induction of polycystic ovary (PCO) due to injection of morphine intra-ventromedial hypothalamus (intra-VMH) of rat compared with the animal receiving the drug (10-100 mg/kg) intraperitoneally (i.p.) twice daily for 7 days to lead to addiction. Materials and Methods: The rats (bought of Pasture Institute of Iran weighing 200-250 g) were housed under standard conditions and fed ad libitum. They were randomly divided to addict to drug or morphine (0.001 to 0.4 μg/rat) receiving into the VMH (AP: -1.92) a week after stereotaxic surgery. Ag-Nps (0.01, 0.001 and 0.0001 μg/rat) were administered intra-VMH alone or prior to morphine effective dose (0.4 μg/rat). Control group was given only saline. By the end of the treatment, the animals’ ovaries and/or brain were dissected and studied histopathologically. The ovaries were also checked by the marker of the NO, NADPH-diaphorase. Results: All experimental rats’ ovaries treated morphine showed polycystic characteristics and the NO activation was evidenced in the ovaries in the comparison with the saline group (p

Keywords


INTRODUCTION

Morphine, an extremely potent opiate analgesic drug that acts by binding to µ-opioid receptors[1, 2], is used to treat of acute and chronic pain. However, the morphine abuse is associated with disadvantages and side effects. Long-term use of the opioid[3,4] is coupled with maleffects and toxicities, e.g. peripheral edema, immune suppression, hyperalgesia, sleep apnea, and changes in endocrine function. Also, there are unfavorable effects on reproductive organs[5-7].

Morphine, the most important alkaloid of opium family which found as much as 10% in opium[6,8], can stimulate the release of nitric oxide (NO) in different tissues[9]. From the past[10] we know that it is an important paracrine messenger. It participates in numerous physiological and pathophysiological procedures in the endocrine system. This free-radical molecule is formed from the conversion of arginine to citrulline by the NO synthase enzyme (NOS)[10]. The molecule is well documented both as a restricted inflammatory generator and included with the factors involved in the ovulatory processes[11,12]. In our recent study[13], we induced the polycystic ovary by injecting morphine into the ventromedial hypothalamus of (VMH) rat. In addition, the slices of morphine-treated rat revealed a significant decrease in the VMH neurons. The Polycystic ovary syndrome (PCOS) is introduced as familiar endocrine disorder that affects approximately 10% of women during their reproductive ages[14]. But so far no solution is presented to prevent this complication. In order to investigate this, we focused on the protective effect of silver nanoparticles (Ag-NPs). The use of Ag-NPs in the industry is increasing, especially in the detergent business. But in use these particles on neural stem cells (in vitro) they showed neurotoxicity[15]. As a reason, when a large number of electrons from a metal nanoparticle are removed from equilibrium, different types of plasmon are produced[16]. This may lead to more permeability of nanoparticles through the cell membrane alive, which can have protective effects. So, we here work on the hypothesis that morphine addiction induces ovarian polycystic, and it also affects the hypothalamus-pituitary-gonad (HPG) axis after intra-VMH infusion. We examine the protection of ovary as well as brain to morphine by Ag-NPs.

MATERIALS AND METHODS

Animals

In this investigational study, the animals were adult female Wistar rats (weight: 200-250 g). Animals were kept under standard temperature (21 ± 3˚C) and 12 hours light / dark cycle with food and water ad libitum. All experiments were conducted according to National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978). We also considered the Guide for the Care and Use of Laboratory Animals[3] and the local Ethical Committee at Shahed University approved it (Approval Notifications 04/17/2014-2017).

Drugs

Morphine sulphate provided by TEMAD co., Tehran, Iran, after confirmation. Ketamine (100 mg) and xylazine (20 mg) were bought of Veterinary Organization of Iran. Nitro blue tetrazolium (NBT), nicotinamide adenine dinucleotide phosphate (NADPH) and violet cresyl were bought from Merck co, Germany. Hematoxylin and eosin were taken of Farzaneh Arman Co., Iran. Silver nano particles (Ag-NPs at sizes 50-60 nm) were provided at this local center with sonoelectrochemistry.

Female Cycle Test

Female rat as been proposed if it is not adjacent to or mated with male rat is always in diestrous[9,10]. The rats thus were kept as virgin to avoid the phase change. Also, the animals’ vaginal samples were examined by vaginal washing between 11:00 am and 12:00 pm and they were screened during the experiment by means of Papanicolaou (PAP) stain. Three types of the epithelial cells, the round and nucleated; and the irregular unnucleated, and the cornified cells, in PAP stained smears were found: The little round cells, the leukocytes were illustrated too. In view of the proportion among them we determined the estrous cycle phases.

Drug administration

Animals (48 rats) were administered morphine progressively (10-100 mg/kg, intra-peritoneally) twice per day for 7 days[17] otherwise the rats were given only saline (control group: 1 mL/kg) during the experimental period. By the end of the treatment, the animals’ ovaries were dissected under deep anesthesia by ketamine (100 mg) and xylazine (20 mg). The collected ovaries were studied histopathologically. They were further analyzed by the nicotinamide adenine dinucleotide phosphate (NADPH) - diaphorase reaction. In using Ag-NPs in 2nd set of animals (72 rats), a week after skull cannulation at anterior-posterior -1.92[18], they were injected morphine (0.001-0.4 µg/rat) and/or Ag-NPs (0.0001-0.01 µg/rat, intra- ventromedial hypothalamus (intra-VMH). The control was microinjected saline (1 µL/rat, intra-VMH). After treatments, the animals’ ovaries and brain were collected in 10% formalin to provide evidence.

Surgery procedure

The treatment groups were deeply anesthetized by ketamine (100 mg) and xylazine (20 mg) used in the ratio of 5 to 2. Then, an incision was created in the lower abdominal part. The ovaries were dissected and examined biometrically. They were then collected in 10% formalin for histological examination. The brain samples after decapitation of rats under deep anesthesia were completely separated; they were finally cut at 3-4 µm after tissue processing.

Histological investigation

To investigate histologically, the ovaries were collected in the 10% formalin solution and they were processed with a tissue processor through paraffin embedding. Serial sections (3-4 μm) were then prepared with a rotary microtome. The ovary slides were stained in the end using the hematoxylin and eosin (H&E) staining method[11] and the brain samples were identified with violet cresyl. The mounted slides were evaluated with a light photomicroscope (Olympus, U.S.A) at 4X-100X.

NADPH-diaphorase reactivity

The enzyme’s ((NOS) activation in the ovarian tissue was shown using the NADPH-diaphorase at the histochemical level. Rats were anesthetized 24 hours after the last injection of morphine addiction dose, the ovaries then were excised and trimmed from periovarian fat and bursae[10,19]. The tissue samples were thus cleared in xylene, hydrated in descending series of ethanol (96%, 95%, 70%, 50%) and rinsed with water. The staining was followed by keeping the slides (24 hours at 37˚C ) in a solution containing equal parts of nitro-blue tetrazolium (NBT, 0.2 mg/mL in phosphate buffer) and NADPH (1 mg/mL in phosphate buffer). Upon reduction by NADPH-diaphorase, NBT yields a blue formazan that is visible by light microscopy[10,20]. Control specimens were assessed using the same procedure except that the specimens were placed in an incubation bath devoid of the marker. No reaction to the NADPH was observed in the control samples. The tissue samples were then dehydrated in ascending series of ethanol (50% 70% 95% 96%), and mounted in Entellan (Merck co., Germany) after being cleared xylene.

Statistical analysis

At first the data were tested by Kolmogorov - Smirnov (K - S) to determine a normal distribution. The statistical comparing was done by SPSS software (version 13.0; SPSS, Inc., Chicago, IL). T-test was used to show differences in average cyst number between groups (control and experimental) in addicted group. The analysis of variance (ANOVA) was applied in experiments with more than two groups. If ANOVA meant it was followed by Tukey’s post hoc. Statistical significance was measured at α < 0.05. All data are expressed as mean ± SEM.

RESULTS

Female cycle

The sexual cycle phase of the female rat was indicated diestrous because there was a plethora of round nucleated epithelial cells in the PAP smears.

Histology

Finally, all animals’ ovaries were dissected, they were then studied histopathologically. The control rats’ ovaries taken from saline - treated group had mature follicles (Fig. 1A) compared with those collected from the morphine addicted group (receiving morphine 10-100 mg/kg, i.p., twice per day during the 7- day period). They exhibited large cysts with thickened granulosa cell layer or large cystic follicles with scant granulosa cells (Fig. 1B). The morphine samples passed the NADPH-diaphorase illustrated the significant (p< 0.05) activation response for NO (Fig. 1C). The cyst’s wall exhibited the blue reaction to the NADPH-diaphorase in contrast to the solely saline group. The above results were also quantified and analyses as significant (p< 0.05).

The ovaries which gathered from rats that were treated morphine intra-VMH also showed polycystic characteristics when compared with the control saline (1 µL/ rat, intra-VMH) samples. However, in the cumulative injection with Ag-NPs, the number of ovarian cysts decreased to control sample size (Fig. 1D-F).

Cyst

The cysts no in all ovaries samples were counted. After analysis, it was shown a significant difference between the control (saline treated) and morphine administered group (p< 0.05). But, in Ag-NPs pre-injection sample, the number of cyst decreased significantly (Fig. 2a-2c).

Neurons of VMH

The VMH’s neurons in morphine microinjected samples were additionally studied. Single Ag-NPs (0.0001-0.01 µg/rat, intra-VMH) samples showed no significant change compared with the control (saline group). Conversely, more damaged neurons were observed in morphine receiving samples than control. This feature was shown regarding the Ag-NPs sample too(p< 0.05) (Fig. 3A-3C).

DISCUSSION

Regarding that the use of opioid substances is addictive, non-clinical consumption of these drugs is called abuse. In this study, we investigated the effect of morphine on addicted rat ovaries. We also examined the morphine-receiving (intra-VMH) animal brain to investigate the protective role of Ag-NPs. Based our finding the ovarian aspect of the morphine addicted rats is similar to ovarian polycystic (PCO). We also showed the role of NO system in inducing this effect by the NADPH-diaphorase reaction.

Evidence indicates the adverse effects of opioid materials on reproductive organs[6]. The drug morphine may disrupt ovarian cycle. Also, long-term use of morphine reduces reproductive activity through noradrenergic mechanisms in the hypothalamus[21].The opioids can attenuate the secretion of sex hormone that increases the likelihood of irregular menstruation as well as infertility [22]. There is other publication which mentions the cellular consequences of the drugs of like nuclear membrane convolution of endometrial epithelial cells[6]. Authors have further demonstrated that morphine can stimulate the NO release in dissimilar endometrial glandular epithelial tissue cells[9,23,24]. The free radical NO is the major inflammatory mediator [25]. This molecule is fromed with metabolic processes by the action of NOS [10]. Although its function during menstruation is almost unclear, however, there is some information about the endometrial NOS expression and NO production during the menstrual cycle that strongly confirm its role in these trends[25]. The NO is commonly categorized as a major paracrine mediator of ovulation, and it has also a regulatory effect in the formation of corpus luteum[26,27]. This laboratory has already[28,29] involved this molecule as the pro-inflammatory element in the PCOS. Morphine abuses as this research indicates, furthermore, caused histological changes (cyst genesis) through the pro-inflammatory NO activation at the follicular walls of ovarian cysts (evidenced by NADPH-diaphorase). This finding is consistent with our previous results, although there was no morphine-addicted animal model[28,29].

Referring to other present finding we may show the unpleasant effect of opioids on the entire HPG axis parts accordingly with the previous report[24] suggesting that opioids can inhibit the functioning of the entire HPG axis by interaction with opioid receptors in the hypothalamus. Opioids also directly bind and inhibit other members of the axis. For example, opioids bind µ-opioid type receptors in the pituitary gland, limiting the production of LH in women, thereby interfering with the menstrual cycle[30]. The aspects of PCOS may vary among individual women as hyperandrogenism, inappropriate gonadotropin secretion, and chronic anovulation are the characteristics of this disorder[31]. It is worth noting that having more than 3 follicular cysts in one or both ovaries is the most common feature. This symptom was induced in all treated animal specimens in the present research, whether addicted or morphine microinjected into the nucleus (VMH). But the important point is the effect of the Ag-NPs on this feature. Because, the polycystic ovarian did not view in the samples received Ag-NPs in the brain, while simultaneously receiving morphine intra- nucleus. Recalling that this work’s goal was to show that relatively low concentration of Ag-NPs interferes with the undesirable effects of morphine on reproductive system, it seems that we achieved this, but we still do not know the underlying mechanism properly. Our finding is in contrast with the published data emphasizing the hazardous effect of the Ag-NPs on neuronal system[15]. It indicates in contrast that Ag-NPs have little poisoning effect at least at these low concentrations. The other opinion is that these particles may be converted into more motile forms of materials which are more diffusible through neuronal cell membrane and created an electrophysiologically evoked medium and/or metabolites. This was previously called plasmon formation[16]. More work on this topic will definitely lead us to more accurate results.

Basically, PCOS, a long lasting features, begins generally in adolescence with oligomenorrhea / amenorrhea and goes toproblems e.g. infertility and metabolic complications and even cancer in the distant future[32,33]. But as present achievement shows the Ag-NPs may inhibit the morphine - induced polycystic by inhibiting the high NO expression in the end organ (ovary) through neuronal protection of hypothalamic axis. There are also suggestions for future study including i.p. administration of the Ag-NPs along with the morphine that can be pursued with seriousness and use of drugs coated with these nanomaterials intra-VMH as some researchers have done[34,35]. Briefly based on present results, we may finish the explanation that the drug abuse or even single use of morphine induces the female gland polycystic probably by activation of pro-inflammation NO pathways and Ag-NPs can be candidate for improving these harmful effects.

CONCLUSION

The Ag-NPs may inhibit the morphine - induced PCO by decreasing the NO expression in the ovary through neuronal protection of the hypothalamic neurons.

CONFLICT OF INTEREST

There is no conflict of interest between authors.

FUNDING

This work was supported in part by the Research deputy at Shahed University in the form of support of the education research plans.

ACKNOWLEDGMENT

The authors thank Mr Sadjad Ebrahimi at Pathology Lab of Shahid Mostafa Hospital who carried out the tissue processing and sectioning under the guidelines by Dr Jalali Nadoushan. We are also thanking to Dr Hajnorouzi for providing the Ag-NPs at Shahed University.

ABBREVIATIONS

Analysis of variance (ANOVA)

Hematoxylin and eosin (H&E)

Intra-peritoneally (i.p)

Kolmogorov - Smirnov (K - S)

Nicotinamide adenine dinucleotide phosphate (NADPH)

Nitric oxide (NO)

Nitroblue tetrazolium (NBT)

NO synthase enzyme (NOS)

Mean of standard error (SEM)

Papanicolaou (PAP)

Polycystic ovary syndrome (PCOS)

Silver nanoparticles (Ag-NPs)

Intra- ventromedial hypothalamus (intra-VMH)

 

1. Inturrisi CE. Clinical Pharmacology of Opioids for Pain. The Clinical Journal of Pain. 2002;18(Supplement):S3-S13.

2. Pasternak GW. Opiate Pharmacology and Relief of Pain. Journal of Clinical Oncology. 2014;32(16):1655-61.

3. Benyamin R, Trescot A, Datta S, Buenaventura R, Adlaka R, Sehgal N. et al., Opioid Complications and Side Effects. Pain Phy 2008;11:S105-S120.

4. Chen A, Ashburn MA. Cardiac Effects of Opioid Therapy. Pain Medicine. 2015;16(suppl 1):S27-S31.

5. Brennan MJ. The Effect of Opioid Therapy on Endocrine Function. The American Journal of Medicine. 2013;126(3):S12-S8.

6. Dehghan M, Jafarpour M, Mahmoudian A. The effect of morphine administration on structure and ultrastructure of uterus in pregnant mice. Iran J Rep Med 2010;8:111-118.

7. Gudin JA, Laitman A, Nalamachu S. Opioid Related Endocrinopathy: Table 1. Pain Medicine. 2015;16(suppl 1):S9-S15.

8. Labanca F, Ovesnà J, Milella L. Papaver somniferum L. taxonomy, uses and new insight in poppy alkaloid pathways. Phytochemistry Reviews. 2018;17(4):853-71.

9. Shafaroodi H, Baradaran N, Moezi L, Dehpour S, Kabiri T, Dehpour AR. Morphine sensitization in the pentylenetetrazole-induced clonic seizure threshold in mice: Role of nitric oxide and μ receptors. Epilepsy & Behavior. 2011;20(4):602-6.

10. Zackris U, Mikuni M, Wallin A, Delbro D, Hedin L, Brannstrom M. Ovary and ovulation: Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation. Human Reproduction. 1996;11(12):2667-73.

11. Nakamura Y, Kashida S, Nakata M, Takiguchi S, Yamagata Y, Takayama H, et al. Changes in Nitric Oxide Synthase Activity in the Ovary of Gonadotropin Treated Rats. The Role of Nitric Oxide during Ovulation. Endocrine Journal. 1999;46(4):529-38.

12. Dhamyaa JH, Maha AA. Evaluation of serum homocysteine and nitric oxide levels in women with polycystic ovarian syndrome and periodontal diseases. Tikrit J Dent Sci 2017;5:57-65.

13. Karimi R, Karami M, Nadoushan MJ. Rat’s Polycystic Ovary Due to Intraventromedial Hypothalamus Morphine Injection. Reproductive Sciences. 2017;25(6):867-72.

14. Baravalle C, Salvetti NR, Mira GA, Pezzone N, Ortega HH. Microscopic Characterization of Follicular Structures in Letrozole-induced Polycystic Ovarian Syndrome in the Rat. Archives of Medical Research. 2006;37(7):830-9.

15. Liu F, Mahmoo M, Xu Y, Watanabe F, Biris AS, Hansen DK. et al., Front Neurosci //doi.org/10.3389/fnins.2015.00115.

16. He YQ, Liu SP, Kong L, Liu ZF. A study on the sizes and concentrations of gold nanoparticles by spectra of absorption, resonance Rayleigh scattering and resonance non-linear scattering. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2005;61(13-14):2861-6.

17. Tang L, Shukla PK, Wang LX, Wang ZJ. Reversal of morphine antinociceotive tolerance and deoendence by the accute supraspinal inhibition of Ca2+/calmodulin dependent protein kinase II. J Pharmacol Exp Ther 2006;317:901-909.

18. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 5th ed, San Diego: Elsevier Academic Press, 2005.

19. Persson L, Rosengren E, Sundler F. Immunohistochemical localization of ornithine decarboxylase in the rat ovary. Histochemistry. 1982;75(2):163-7.

20. Tracey WR, Nakane M, Pollock JS, Forstermann U. Nitric Oxide Synthases in Neuronal Cells, Macrophages and Endothelium Are NADPH Diaphorases, but Represent Only a Fraction of Total Cellular NADPH Diaphorase Activity. Biochemical and Biophysical Research Communications. 1993;195(2):1035-40.

21. Siddiqui A, Haq S, Shah BH. Perinatal Exposure to Morphine Disrupts Brain Norepinephrine, Ovarian Cyclicity, and Sexual Receptivity in Rats. Pharmacology Biochemistry and Behavior. 1997;58(1):243-8.

22. Daniell HW. Opioid Endocrinopathy in Women Consuming Prescribed Sustained-Action Opioids for Control of Nonmalignant Pain. The Journal of Pain. 2008;9(1):28-36.

23. Tseng L, Mazella J, Goligorsky MS, Rialas CM, Stefano GB. Dopamine and Morphine Stimulate Nitric Oxide Release in Human Endometrial Glandular Epithelial Cells. Journal of the Society for Gynecologic Investigation. 2000;7(6):343-7.

24. Katz N, Mazer NA. The Impact of Opioids on the Endocrine System. The Clinical Journal of Pain. 2009;25(2):170-5.

25. Chwalisz K, Garfield RE. Role of nitric oxide in implantation and menstruation. Human Reproduction. 2000;15(suppl 3):96-111.

26. Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology. 1994;135(5):2287-90.

27. Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E, et al. Inhibition of Nitric Oxide: Effects on Interleukin-lβ-Enhanced Ovulation Rate, Steroid Hormones, and Ovarian Leukocyte Distribution at Ovulation in the Rat1. Biology of Reproduction. 1996;54(2):436-45.

28. Hassani F, Karami M, JalaliNadoushan M, EftekhariYazdi P. Nitric oxide-induced polycystic ovaries in the Wistar rat. Int J Fertil Steril 2012;6:111-116.

29. Lakzaei F, Karami M, Darban Fooladi M, Jalali Nodoushan M. Pathological characteristics of uterus in rats with polycystic ovary. J Bas Clin Pathophysiol 2013;1:29-33.

30. Colameco S, Coren JS. Opioid-induced endocrinopathy. J Am Osteopath Assoc 2009;109:20-25.

31. Zafari M, Tofighi M, Aghamohammady A, Behmanesh F, Rakhshaee Z. Comparison of the effect of acupressure, fish oil capsules and ibuprofen on treatment of primary dysmenorrhea. Af J Pharm Pharmacol 2011;5(8):1115-1119.

32. Mallappa Saroja CS, Hanji Chandrashekar S. Polycystic ovaries: review of medical information on the internet for patients. Archives of Gynecology and Obstetrics. 2010;281(5):839-43.

33. Marshall K. Polycystic Ovary Syndrome: Clinical Considerations. Alt Med Rev 2001; 6:272-292.

34. Aminee F. The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat. Rep Med 2011; 283:885-892.

35. Gharedaghi M, Dehpour AR. Effect of morphine on the reduced uteroplacental perfusion model of pre-eclampsia in rats. Eur J Obs Gynecol Rep Biol 2013;168:161-166.